[1]
Divino, BA, V., Cepeda, MD, PhD, M.S., Coplan, ScD, MBA, MPH, P., Maziere, MD, PhD, J.-Y., Yuan, PhD, Y. and Wade, RPh, MS, R.L. 2017. Assessing the impact of the extended-release/long-acting opioid analgesics risk evaluation and mitigation strategies on opioid prescription volume. Journal of Opioid Management. 13, 3 (May 2017), 157–168. DOI:https://doi.org/10.5055/jom.2017.0383.